Here’s Why Sarepta Invested in a Departing Exec’s New Startup

One of Sarepta Therapeutics‘ longtime executives, Alexander “Bo” Cumbo, is leaving the company to launch a new gene therapy company — and his former employer is getting involved. 

Sarepta has invested $15 million in UF startup and UF Innovate | The Hub resident client AavantiBio, which launched Thursday with a total of $107 million. The startup will be led by Cumbo, who has been Sarepta’s chief commercial officer since 2013. Cumbo will work with Sarepta in an advisory role through the end of the year. 

Read more about Here’s Why Sarepta Invested in a Departing Exec’s New Startup.